Categories

Volume 7 Issue 11 (November, 2019)

Original Articles

Assessment of the efficacy of Bupivacaine and Methylprednisolone for Arthrocentesis of TMJ disorders
Y K Pahadia, Deepa Awathi, Abhishek Pathak

Background: The signs and symptoms of TMD involve orofacial and preauricular pain, as well as limitation of mouth opening, TMJ bruit during function and displacement of articular disc. The present study was conducted to assess efficacy of bupivacaine and methylprednisolone for arthrocentesis of TMJ disorders. Materials & Methods: The present study was done on 72 patients with TMJ disorders. Patients were divided into 2 groups of 36 each. Group I patients received bupivacaine and group II patients received methylprednisolone acetate. Pain was assessed using VAS scale and mouth opening was determined. Results: Out of 72 patients, males were 30 and females were 42. The mean VAS score pre- operatively in group I was 8.2, after 1 month was 4.1 and after 3 months was 2.0. Similarly in group II was 9.1, 4.0 and 1.2 respectively. The difference was significant (P< 0.05). The mean mouth opening in group I was 25.2 mm and in group II was 25.6 mm, post- operatively 1 month was 35.8 mm in group I and 40.2 mm in group II, after 3 months was 41.5 mm in group I and 46.3 mm in group II. The difference was significant (P< 005). Conclusion: Authors found significantly reduction in pain score and increase in mouth opening with methyl prednisolone as compared to bupivacaine following treatment. Key words: Methyl prednisolone, mouth opening, VAS

 
Abstract View | Download PDF | Current Issue